Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial by Mega, JL, MD, Braunwald, E, Prof, Mohanavelu, S, MS, Burton, P, MD, Poulter, R, MB, Misselwitz, F, MD, Hricak, V, Prof, Barnathan, ES, MD, Bordes, P, MD, Witkowski, A, Prof, Markov, V, Prof, Oppenheimer, L, PhD, Gibson, CM, MD

Get full text